CARCINOEMBRYONIC ANTIGEN (CEA) IN OVARIAN CANCER: FACTORS INFLUENCING ITS INCIDENCE AND CHANGES WHICH OCCUR IN RESPONSE TO CYTOTOXIC DRUGS

We report the serum levels of carcinoembryonic antigen (CEA) in 109 patients with ovarian cancer. Histology, degree of differentiation, and clinical stage influenced the incidence of positive CEA. Although CEA was significantly raised in patients with a variety of tumours, the highest incidence (77 per cent) was found in those with serous cystadenocarcinoma. Nearly all (94 per cent) of the poorly differentiated tumours were associated with a positive CEA result. Serial CEA levels provided a useful guide to management during cytotoxic chemotherapy, rapidly falling levels indicating a favourable tumour response which was reflected clinically. However, only two‐thirds of tumours were associated with detectable CEA levels in serum, day‐to‐day variations in individual serum levels occurred, and CEA levels tended to fall paradoxically during terminal illness. The significance of persistently low levels in the apparent absence of disease was uncertain.

[1]  S. Knauf,et al.  Quantitation of antigens in normal and malignant ovarian tissue. , 1975, American journal of obstetrics and gynecology.

[2]  J. Barlow,et al.  Tumor markers in ovarian cancer: tumor-associated antigens. , 1975, Seminars in oncology.

[3]  E. Ruoslahti,et al.  Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract , 1975, Cancer.

[4]  J. van Nagell,et al.  Carcinoembryonic antigen in patients with gynecologic malignancy , 1975, Cancer.

[5]  J. Woodruff,et al.  Biologic Behavior of Primary Ovarian Malignancy , 1974, Obstetrics and gynecology.

[6]  E. Mackay,et al.  Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long‐term followup of female genital cancer , 1974, Cancer.

[7]  S. Knauf,et al.  Ovarian tumor-specific antigens. , 1974, American journal of obstetrics and gynecology.

[8]  N. Zamcheck,et al.  Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer , 1974, Cancer.

[9]  N. Zamcheck,et al.  Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress , 1974, Cancer.

[10]  I. Mackay,et al.  Carcinoembryonic antigenic activity of tissue extracts: A quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs , 1973, International journal of cancer.

[11]  E. Mackay,et al.  Carcinoembryonic Antigen in Cancer of the Female Reproductive System: Its Detection in Serum by a Microradioimmunoassay* , 1973, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  E. Mackay,et al.  Carcinoembryonic Antigen in Cancer of the Female Reproductive System Sequential Levels and Effects of Treatment* , 1973, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  J. Pearl,et al.  Demonstration of tumor-associated antigens in human gynecologic malignancies. , 1973, American journal of obstetrics and gynecology.

[14]  A. Neville,et al.  Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial Carcinoma , 1972, British medical journal.

[15]  P. Gold,et al.  Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system. , 1972, Nature: New biology.

[16]  N. Zamcheck,et al.  Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens. , 1972, The New England journal of medicine.

[17]  P. Gold,et al.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. , 1969, Proceedings of the National Academy of Sciences of the United States of America.